Skip navigation
Skip navigation
You are using an outdated browser. Please upgrade your browser.
Gamlen Tableting D series instrument

Gamlen Tableting will be presenting seven posters at AAPS 2016

Gamlen Tableting will be exhibiting at the forthcoming 2016 American Association of Pharmaceutical Scientists Annual Meeting and Exposition (AAPS), 13th-17th November, at the Colorado Convention Center, Denver (Booth Number 868).

Gamlen Tableting will be demonstrating Gamlen’s new manufacturability protocol which utilises data captured by the Gamlen D Series Powder Compaction Analyzer to determine whether a powder will make a good tablet. This straightforward assessment of powder properties requires just 15-25 tablets that are compressed under tightly controlled conditions using the Gamlen D Series instrument.

In addition, Gamlen Tableting will be presenting seven posters at AAPS 2016 on a range of topics including: applications of the manufacturability protocol, the relationship between material and tablet properties, the effect of dwell time on tablet compressibility and the measurement of elastic recovery during and after tablet compression.

Gamlen Tableting offers a range of easy-to-use bench top compaction instruments that are computer-controlled and designed for industry researchers and academics to safely explore the impact of materials and process variables on powder compaction and tablet manufacture.

For further information about the Gamlen Tableting range of powder compaction analyzers and tablet presses visit: or telephone Gamlen Tableting Limited on: +44 (0)115 912 4271 to arrange a demonstration.


Additional information

• Gamlen Tableting was established in 2011 by Dr Michael Gamlen who has over 40 years’ experience in tablet development. Michael was Head of Tablet Development at The Wellcome Foundation for 15 years. He specialises in managing product development, formulation, and tablet and process development studies.

• Gamlen instruments are used by pharmaceutical companies and prominent university teaching and research programs worldwide.

For corporate and sales enquiries or to request a demonstration, please contact:

Dr Michael Gamlen
Managing Director
Gamlen Tableting Limited

Registered office:
Biocity Nottingham
Pennyfoot Street
United Kingdom

London office and demonstration laboratory:
Yeoman House
63 Croydon Road
SE20 7TS
United Kingdom

Tel: +44 115 912 4271

For press enquiries, please contact:

Philippa Bevan
Gamlen Tableting
Tel: +44 1785 747 102 (direct)

This press release was distributed by ResponseSource Press Release Wire on behalf of Gamlen Tableting in the following categories: Medical & Pharmaceutical, for more information visit